RS

Ritu Sharma

Active Director Director DIN 10057645
DIN 10057645 First appointment Sep 2023 Primary industry Electrnoics
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2023
Shareholding value •••• Premium profile

About Ritu Sharma

Data last updated:

Ritu Sharma is a Director at Jannocks Pharma Private Limited (since 2023). The company operates in Electrnoics. Jannocks Pharma Private Limited reported revenue of ₹11 Lakh (FY 2024).

DIN 10057645
Primary Designation Director
Industry Electrnoics
First Appointment 20 Sep 2023
Oldest Company Age 6 yrs
Largest company Jannocks Pharma Private Limited · ₹11 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jannocks Pharma Private Limited U52601DL2020PTC370138
Director20 Sep 20232020₹11 Lakh (FY 2024)Active

Board colleagues of Ritu Sharma

Directorship timeline

Open interactive timeline →
Jannocks Pharma Private Limited
Premium access

Shareholding and investment profile for Ritu Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritu Sharma

Ritu Sharma currently holds 1 directorship: Jannocks Pharma Private Limited (Director, since 20 Sep 2023, revenue ₹11 Lakh (FY 2024)).

Ritu Sharma was first appointed on 20 Sep 2023 as Director at Jannocks Pharma Private Limited.

The current boards of Ritu Sharma's companies include Kalpana (Jannocks Pharma Private Limited), Akash Kumar (Jannocks Pharma Private Limited), Anita Rathore (Jannocks Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available